ChrysCapital buys 12.5 per cent stake in Intas
NEW DELHI: Private equity major ChrysCapital has acquired 12.5 per cent equity stake in Ahmedabad-based pharma company Intas Pharmaceuticals for around Rs 53 crore.
The stake was acquired from ICICI Ventures. The deal which was signed on Wednesday, marks ChrysCapitals foray in pharma space, sources said.
The acquisition will be done through Mozart, a Mauritius-based subsidiary of ChrysCapital III.
ChrysCapital senior MD Ashish Dhawan told TOI “We are delighted to invest in the pharma sector, for which we have the requisite experience and the expertise within the firm.”
SOURCE:THE TIMES OF INDIA
THE Income-Tax Department conducted search operations in two major pharmaceutical companies and a bakery chain. The pharma majors are Cipla Read more
INCOME-TAX authorities today raided the premises of Great Eastern Shipping Company, Ipca Laboratories and RNA Builders. Altogether, 40 premises have Read more
LONDON: A Non-Resident Indian plastic surgeon, who falsely claimed that his sister and uncle were killed in the September 11 Read more
NEW DELHI: San Francisco-based Farallon Capital Management, L.L.C. has invested Rs 88 crore for 33.3% stake in Indiabulls Credit Services Read more
